December 20, 2016
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
Salutaris receives 510(k) clearance for radionuclide brachytherapy device
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
The FDA has granted 510(k) clearance for the SMD-Sr90-DA Radionuclide Brachytherapy Source, according to a press release from Salutaris Medical Devices.
The device, indicated for episcleral brachytherapy, is to be used within a manual brachytherapy applicator system.
Salutaris’ technology is aimed at improving outcomes for wet age-related macular degeneration.